A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimer’s Disease (TargetTau-1)
Open
- Protocol code: CN008-0003
- EudraCT code: No aplica
- Research group: Neurovascular Diseases
- Service: Neurology
- Principal investigator: Delgado Martínez, Maria Pilar
- Pathology: Malalties del sistema nerviós
- Phase: Fase II